Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.
Blood Cancer J. 2024 May 31;14(1):92. doi: 10.1038/s41408-024-01073-z.
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma with sparse tumor B-cells and a favorable prognosis. Variant growth patterns of NLPHL, however, often show advanced stage, progression to T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL) and a worse prognosis. We studied the tumor microenvironment (TME) of NLPHL and THRLBCL using highplex imaging and spatial profiling at the single cell level. Our findings show distinct differences in TME composition and spatial configuration that differ among typical and variant NLPHL and THRLBCL. Typical NLPHL show abundant helper T-cell subsets, while THRLBCL show abundant cytotoxic T-cells and macrophages. Tumor B-cell size and content is lowest in typical NLPHL, followed by variant NLPHL, and highest in THRLBCL, whereas an opposite trend characterized TME B-cells. CD4/CD8 double-positive T-cells are seen in all NLPHL but not in the majority of THRLBCL and are spatially distant from LP-cells and TFH-rosettes. The differences in macrophage/monocyte content in distinguishing NLPHL pattern E from THRLBCL is further corroborated in independent cohorts of cases. Our results validate the current approach to classification and in addition provide novel insights that could be leveraged to refine clinical management for patients with this spectrum of lymphomas.
结节性淋巴细胞为主型霍奇金淋巴瘤(NLPHL)是一种罕见的淋巴瘤,其肿瘤 B 细胞稀少,预后良好。然而,NLPHL 的变异生长模式常表现为晚期、进展为 T 细胞/组织细胞丰富的大 B 细胞淋巴瘤(THRLBCL),且预后较差。我们使用高内涵成像和单细胞水平的空间分析研究了 NLPHL 和 THRLBCL 的肿瘤微环境(TME)。我们的研究结果表明,在 NLPHL 和 THRLBCL 中,TME 组成和空间结构存在明显差异,且在典型 NLPHL 和变异 NLPHL 以及 THRLBCL 之间存在差异。典型 NLPHL 中存在丰富的辅助性 T 细胞亚群,而 THRLBCL 中存在丰富的细胞毒性 T 细胞和巨噬细胞。肿瘤 B 细胞的大小和含量在典型 NLPHL 中最低,其次是变异 NLPHL,在 THRLBCL 中最高,而相反的趋势是 TME B 细胞。所有 NLPHL 中都可见 CD4/CD8 双阳性 T 细胞,但在大多数 THRLBCL 中未见,且与 LP 细胞和 TFH 玫瑰花结空间上远离。在区分 NLPHL 模式 E 和 THRLBCL 中,巨噬细胞/单核细胞含量的差异在独立病例队列中得到进一步证实。我们的研究结果验证了当前的分类方法,此外还提供了新的见解,可用于为该系列淋巴瘤患者的临床管理提供参考。